{
  "id": 1407,
  "text": "Investigating whether high dose-rate intracavitary brachytherapy dose ratios can predict treatment outcomes in patients with stage IIB cervical cancer, Cho et al.1258 found that the 5- year DSS and PFS rates were significantly lower in the group with low high-dose rate intracavitary brachytherapy ratio compared to the group with the high high-dose rate intracavitary brachytherapy ratio (5-year DSS: $7 8 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Investigating whether high dose-rate intracavitary brachytherapy dose ratios can predict treatment outcomes in patients with stage IIB cervical cancer, Cho et al.1258 found that the 5- year DSS and PFS rates were significantly lower in the group with low high-dose rate intracavitary brachytherapy ratio compared to the group with the high high-dose rate intracavitary brachytherapy ratio (5-year DSS\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "宫颈癌II期B患者在接受高剂量率腔内近距离放疗时，剂量比确实能够预测治疗效果。研究表明，对于高剂量率较高的患者，其5年疾病特异生存率（DSS）和无进展生存率（PFS）显著高于剂量率较低的患者。这意味着高剂量率腔内近距离放疗的剂量比可以作为一个潜在的预后指标，帮助预测患者在治疗后的长期生存效果。因此，在治疗决策中考虑剂量率可能对于优化治疗结果具有重要意义。",
  "query": "对于II期B宫颈癌患者，高剂量率腔内近距离放疗的剂量比是否能够预测治疗效果？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于II期B宫颈癌患者，高剂量率腔内近距离放疗的剂量比是否能够预测治疗效果？\n\n<reference text>: Investigating whether high dose-rate intracavitary brachytherapy dose ratios can predict treatment outcomes in patients with stage IIB cervical cancer, Cho et al.1258 found that the 5- year DSS and PFS rates were significantly lower in the group with low high-dose rate intracavitary brachytherapy ratio compared to the group with the high high-dose rate intracavitary brachytherapy ratio (5-year DSS: $7 8 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "宫颈癌II期B患者在接受高剂量率腔内近距离放疗时，剂量比确实能够预测治疗效果。研究表明，对于高剂量率较高的患者，其5年疾病特异生存率（DSS）和无进展生存率（PFS）显著高于剂量率较低的患者。这意味着高剂量率腔内近距离放疗的剂量比可以作为一个潜在的预后指标，帮助预测患者在治疗后的长期生存效果。因此，在治疗决策中考虑剂量率可能对于优化治疗结果具有重要意义。"
}